Pliant Therapeutics Overview
Pliant Therapeutics Target Price
Analysts' 12-month price predictions for PLRX.
Get informed when a big investor buys or sells
+ FollowShare Price
$1.18
Average Target Price
$3.00
154.2% upside
154.2% upside1 analysts in the last 4 months
High: $3 | Low: $3
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-03-12 | Piper SandlerYasmeen Rahimi | $3 | 154.2% upside |  |
| 2025-03-03 | Stifel Nicolaus | $3 | 154.2% upside | |
| 2025-03-03 | Leerink Partners | $2 | 69.5% upside | |
| 2024-09-13 | H.C. WainwrightEd Arce | $38 | 3120.3% upside | |
| 2024-09-09 | Leerink PartnersFaisal Khurshid | $33 | 2696.6% upside | |
| 2024-05-23 | Piper SandlerYasmeen Rahimi | $40 | 3289.8% upside | |
| 2024-05-07 | Stifel NicolausAlex Thompson | $32 | 2611.9% upside | |
| 2024-05-07 | OppenheimerJeff Jones | $48 | 3967.8% upside | |
| 2024-05-07 | H.C. WainwrightEd Arce | $36 | 2950.8% upside | |
| 2024-05-07 | RBC CapitalBrian Abrahams | $45 | 3713.6% upside | |
| 2022-12-07 | J.P. Morgan | $42 | 3459.3% upside | |